StoneCo Ltd (STNE) concluded trading on Wednesday at a closing price of $10.73, with 4.11 million shares of worth about $44.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.71% during that period and on April 03, 2025 the price saw a gain of about 1.51%. Currently the company’s common shares owned by public are about 269.09M shares, out of which, 228.28M shares are available for trading.
Stock saw a price change of -5.79% in past 5 days and over the past one month there was a price change of 17.52%. Year-to-date (YTD), STNE shares are showing a performance of 34.63% which decreased to -34.25% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.72 but also hit the highest price of $17.93 during that period. The average intraday trading volume for StoneCo Ltd shares is 6.45 million. The stock is currently trading 3.27% above its 20-day simple moving average (SMA20), while that difference is up 10.04% for SMA50 and it goes to -1.15% lower than SMA200.
StoneCo Ltd (NASDAQ: STNE) currently have 269.09M outstanding shares and institutions hold larger chunk of about 77.08% of that.
The stock has a current market capitalization of $2.94B and its 3Y-monthly beta is at 2.07. It has posted earnings per share of -$0.85 in the same period. It has Quick Ratio of 1.42 while making debt-to-equity ratio of 1.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STNE, volatility over the week remained 3.21% while standing at 4.13% over the month.
Stock’s fiscal year EPS is expected to rise by 2.32% while it is estimated to increase by 18.71% in next year.
Coverage by Morgan Stanley stated StoneCo Ltd (STNE) stock as an Underweight in their note to investors on September 05, 2024, suggesting a price target of $7 for the stock. On July 08, 2024, UBS Upgrade their recommendations, while on June 06, 2024, JP Morgan Upgrade their ratings for the stock with a price target of $20. Stock get a Neutral rating from UBS on February 01, 2024.
